NCT04157985 2025-12-11Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsUniversity of PittsburghPhase 3 Completed161 enrolled
NCT03693014 2025-10-06A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint InhibitorsMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting69 enrolled
NCT03289962 2025-07-04A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsGenentech, Inc.Phase 1 Completed272 enrolled